Month: July 2016

Annual Laurencin Labs Dinner

By Cato T. Laurencin, M.D., Ph.D.

Laurencin Labs Annual Dinner 2016On Friday, July 22, the Institute for Regenerative Engineering held our 29th Annual Laurencin Labs dinner at the Hartford Golf Club in West Hartford. Over 60 graduate students, postdoctoral fellows, and faculty members attended. Also attending were the local high-school and college students who are spending part of their summers in the lab. The evening celebrated the outstanding research conducted in our laboratory during 2016 and included a discussion of the work planned for 2017.

Thank you to those who helped make this the dinner meeting so successful.

Lakshmi Nair Edits Book on Injectable Hydrogels

Injectable Hydrogels for Regenerative EngineeringI am pleased to announce IRE faculty member Lakshmi Nair recently served as editor of a new book, Injectable Hydrogels for Regenerative Engineering.

Regenerative engineering, with its ability to foster novel therapeutic techniques and strategies, has emerged as the most versatile and innovative technology of the 21st century. The past few years have seen significant research interest in the design, preparation, and application of injectable hydrogels as advanced biomaterials for cell and factor therapy. This book is timely, providing a state-of-the-art summary of the status of injectable hydrogels in regenerative engineering. The collection of ten chapters written by experts in their fields presents an excellent overview of the subject for a wide audience. In my opinion, this book will be extremely useful as a reference source for all those working in the area of biomaterials, tissue engineering, regenerative medicine, and drug delivery.

Convergence Report Release

By Cato T. Laurencin, M.D., Ph.D.

It was a great pleasure to appear as a member of the study panel at the Convergence Report Release Event in Washington D.C. on June 24. The report, “Convergence: The Future of Health”, draws on insights from several dozen expert participants at two workshops, as well as containing input from scientists and researchers from academia, industry, and government. Their efforts have produced a wide range of recommendations for advancing convergence research. The report outlines three major disease areas — brain disorders, infectious diseases and immunology, and cancer — and promises convergence-based approaches to tackling them. It also presents case studies of four emerging technology categories: advanced imaging in the body, nanotechnology for drug and therapy delivery, regenerative engineering, and big data and health information technology.  The report was co-chaired by Tyler Jacks, the David H. Koch Professor of Biology and director of MIT’s Koch Institute for Integrative Cancer Research; Susan Hockfield, neuroscientist and president emerita of MIT; and Phillip Sharp, Institute Professor at MIT and Nobel Laureate.

The panel discussion is online, please watch the video.